May 13, 2020
Artax Biopharma Appoints Joseph Lobacki as Chief Executive Officer, Announces Expanded Management Team
May 13, 2020
Sanofi to showcase oncology portfolio and innovative pipeline at ASCO20 Virtual Scientific Program
May 13, 2020
Regeneron Presentations at ASCO 2020 Showcase Diverse Clinical Oncology Portfolio
May 11, 2020
Regeneron and Colorado Center for Personalized Medicine Announce Major New Human Genetics Research Collaboration
May 11, 2020
Protalix BioTherapeutics Announces Positive Topline Results from the BRIDGE Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa for the Treatment of Fabry Disease
May 05, 2020
Jupiter Orphan Therapeutics, Inc. Strengthens its Advisory Positions
May 05, 2020
Libtayo® (cemiplimab) Shows Clinically-Meaningful and Durable Responses in Second-line Advanced Basal Cell Carcinoma
Apr 28, 2020
CANbridge Pharmaceuticals Appoints Acting Chief Scientific Officer
Apr 28, 2020
The Global Epinephrine Autoinjector Market is expected to grow by $ 762.51 mn during 2020-2024 progressing at a CAGR of 7% during the forecast period
Apr 27, 2020
Phase 3 Trial of Libtayo® (cemiplimab) as Monotherapy for First-Line Advanced Non-small Cell Lung Cancer Stopped Early Due to Highly Significant Improvement in Overall Survival
Apr 27, 2020
Regeneron and Sanofi Provide Update on U.S. Phase 2/3 Adaptive-Designed Trial of Kevzara® (sarilumab) in Hospitalized COVID-19 Patients
Apr 24, 2020
Sanofi at forefront of fight against COVID-19 in Q1 2020
Apr 23, 2020
The Global Epinephrine Auto-injector Market to Reach Revenues of Over $2 Billion During the Period 2020 -2025 - Market Research by Arizton
Apr 22, 2020
Influenzavirus B Infections - Pipeline Review, H1 2020
Apr 22, 2020
Tetanus - Pipeline Review, H1 2020
Apr 16, 2020
FDA Accepts for Priority Review Biologics License Application for REGN-EB3 to Treat Ebola
Apr 14, 2020
Worldwide Licensing Partnering Deals in Pharma, Biotech & Diagnostics, 2014-2020
Apr 09, 2020
Collaborative R&D Partnering Deals in Pharma, Biotech & Diagnostics 2014-2020: A Comprehensive Listing of 5,000+ Collaborative R&D Deals
Apr 09, 2020
Royalty Rates in Worldwide Pharma & Biotech Dealmaking 2010-2020: Case Studies, Trends, Leading Deals and More
Apr 09, 2020
Global Pharma, Biotech & Diagnostics Co-promotion & Co-marketing Partnering Terms & Agreements Report, 2014-2020